BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19432721)

  • 1. Reporting of minimum clinically important differences in surgical trials.
    Kashani I; Hall JL; Hall JC
    ANZ J Surg; 2009 Apr; 79(4):301-4. PubMed ID: 19432721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size calculations in surgery: are they done correctly?
    Maggard MA; O'Connell JB; Liu JH; Etzioni DA; Ko CY
    Surgery; 2003 Aug; 134(2):275-9. PubMed ID: 12947329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the minimum clinically important difference and its impact on designing a trial.
    Chuang-Stein C; Kirby S; Hirsch I; Atkinson G
    Pharm Stat; 2011; 10(3):250-6. PubMed ID: 20936625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
    Li B; Grambsch P
    Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in the quality of randomized controlled trials among general anesthesiology journals 2000 to 2006: a 6-year follow-up.
    Greenfield ML; Mhyre JM; Mashour GA; Blum JM; Yen EC; Rosenberg AL
    Anesth Analg; 2009 Jun; 108(6):1916-21. PubMed ID: 19448222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing quality of reports on randomized clinical trials in nursing journals.
    Parent N; Hanley JA
    Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal.
    Dechartres A; Boutron I; Roy C; Ravaud P
    J Clin Epidemiol; 2009 Jul; 62(7):695-702. PubMed ID: 19135860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical guides to understanding sample size and minimal clinically important difference (MCID).
    Neely JG; Karni RJ; Engel SH; Fraley PL; Nussenbaum B; Paniello RC
    Otolaryngol Head Neck Surg; 2007 Jan; 136(1):14-8. PubMed ID: 17210326
    [No Abstract]   [Full Text] [Related]  

  • 10. Consultants' forum: should post hoc sample size calculations be done?
    Walters SJ
    Pharm Stat; 2009; 8(2):163-9. PubMed ID: 18416448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials.
    Chen H; Zhang N; Lu X; Chen S
    Clin Trials; 2013 Aug; 10(4):522-9. PubMed ID: 23794405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The variability in minimal clinically important difference and patient acceptable symptomatic state values did not have an impact on treatment effect estimates.
    Tubach F; Giraudeau B; Ravaud P
    J Clin Epidemiol; 2009 Jul; 62(7):725-8. PubMed ID: 19128938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design and interpretation of pilot trials in clinical research in critical care.
    Arnold DM; Burns KE; Adhikari NK; Kho ME; Meade MO; Cook DJ;
    Crit Care Med; 2009 Jan; 37(1 Suppl):S69-74. PubMed ID: 19104228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of 'retropro' studies in the surgical literature.
    Hall JC; Hall JL
    ANZ J Surg; 2008 May; 78(5):411-3. PubMed ID: 18380746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simulation study of sample size for multilevel logistic regression models.
    Moineddin R; Matheson FI; Glazier RH
    BMC Med Res Methodol; 2007 Jul; 7():34. PubMed ID: 17634107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining a minimum clinically important difference between treatments for a patient-reported outcome.
    Kirby S; Chuang-Stein C; Morris M
    J Biopharm Stat; 2010 Sep; 20(5):1043-54. PubMed ID: 20721790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size calculations for 3-level cluster randomized trials.
    Teerenstra S; Moerbeek M; van Achterberg T; Pelzer BJ; Borm GF
    Clin Trials; 2008; 5(5):486-95. PubMed ID: 18827041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Back to basics: explaining sample size in outcome trials, are statisticians doing a thorough job?
    Carroll KJ
    Pharm Stat; 2009; 8(4):333-45. PubMed ID: 19180520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining survival as an outcome measure in amyotrophic lateral sclerosis.
    Gordon PH; Corcia P; Lacomblez L; Pochigaeva K; Abitbol JL; Cudkowicz M; Leigh PN; Meininger V
    Arch Neurol; 2009 Jun; 66(6):758-61. PubMed ID: 19506136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety reporting in randomized clinical trials - a need for improvement.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2009; 67(2):209-10. PubMed ID: 19583556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.